CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity

Acta Neuropathologica

Volumn 128, Issue 2, 2014, Pages 291-303

  Spence, Tara ^a,b   Sin Chan, Patrick ^a,b   Picard, Daniel ^a   Barszczyk, Mark ^a   Hoss, Katharina ^a   Lu, Mei ^a   Kim, Seung Ki ^c   Ra, Young Shin ^d   Nakamura, Hideo ^e   Fangusaro, Jason ^f   Hwang, Eugene ^g   Kiehna, Erin ^h   Toledano, Helen ⁱ   Wang, Yin ^j   Shi, Qing ^k   Johnston, Donna ^l   Michaud, Jean ^l   La Spina, Milena ^m   Buccoliero, Anna Maria ⁿ   Adamek, Dariusz ^o   Camelo Piragua, Sandra ^p   Peter Collins, V ^q   Jones, Chris ^r   Kabbara, Nabil ^s   Jurdi, Nawaf ^t   Varlet, Pascale ^u   Perry, Arie ^v   Scharnhorst, David ^w   Fan, Xing ^p   Muraszko, Karin M ^p   Eberhart, Charles G ^x   Ng, Ho Keung ^y   Gururangan, Sridharan ^z   Van Meter, Timothy ^aa   Remke, Marc ^a   Lafay Cousin, Lucie ^ab   Chan, Jennifer A ^ac   Sirachainan, Nongnuch ^ad   Pomeroy, Scott L ^ae   Clifford, Steven C ^af   Gajjar, Amar ^ag   Shago, Mary ^a   Halliday, William ^a   Taylor, Michael D ^a   Grundy, Richard ^ah   Lau, Ching C ^ai   Phillips, Joanna ^v   Bouffet, Eric ^a   Dirks, Peter B ^a   Hawkins, Cynthia E ^a,b   Huang, Annie ^a,b   more..

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Seoul National University Children's Hospital   (South Korea)

^d Asan Medical Center   (South Korea)

^e KUMAMOTO UNIVERSITY   (Japan)

^f CHILDREN'S MEMORIAL HOSPITAL   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h CHILDREN S HOSPITAL LOS ANGELES   (United States)

ⁱ Schneider Children Hospital   (Israel)

^j FUDAN UNIVERSITY   (China)

^k SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^l CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^m UNIVERSITY OF CATANIA   (Italy)

ⁿ UNIVERSITY OF FLORENCE   (Italy)

^o JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^p UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^q UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^r INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^s RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^t AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^u CENTRE HOSPITALIER SAINTE ANNE   (France)

^v UNIVERSITY OF CALIFORNIA   (United States)

^w CHILDREN S HOSPITAL CENTRAL CALIFORNIA   (United States)

^x JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^z DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aa VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ab ALBERTA CHILDREN'S HOSPITAL   (Canada)

^ac UNIVERSITY OF CALGARY   (Canada)

^ad MAHIDOL UNIVERSITY   (Thailand)

^ae BOSTON CHILDREN S HOSPITAL   (United States)

^af NEWCASTLE UNIVERSITY   (United Kingdom)

^ag ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^ah QUEEN S MEDICAL CENTRE   (United Kingdom)

^ai BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3B; LIN28 PROTEIN; MICRORNA; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; DNA (CYTOSINE 5) METHYLTRANSFERASE; LIN-28 PROTEIN, HUMAN; LIN28B PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; BRAIN; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; DNA METHYLATION; EPENDYMOBLASTOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROECTODERM TUMOR; NEUROEPITHELIOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADOLESCENT; BRAIN NEOPLASMS; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; INFANT; METABOLISM; MULTIGENE FAMILY; NEUROECTODERMAL TUMORS, PRIMITIVE; ONSET AGE; TUMOR CELL LINE;

ADOLESCENT; AGE OF ONSET; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; MALE; MICRORNAS; MULTIGENE FAMILY; NEUROECTODERMAL TUMORS, PRIMITIVE; RNA-BINDING PROTEINS;

EID: 84906936263     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1291-1     Document Type: Article

References (22)

1. Adamek D, Sofowora KD, Cwiklinska M, Herman-Sucharska I, Kwiatkowski S (2013) Embryonal tumor with abundant neuropil and true rosettes: an autopsy case-based update and review of the literature. Childs Nerv Syst 29:849-854. doi:10.1007/s00381-013-2037-4
2. Buccoliero AM, Castiglione F, Rossi Degl'Innocenti D et al (2010) Embryonal tumor with abundant neuropil and true rosettes: morphological, immunohistochemical, ultrastructural and molecular study of a case showing features of medulloepithelioma and areas of mesenchymal and epithelial differentiation. Neuropathology 30:84-91. doi:10.1111/j.1440-1789.2009.01040.x
3. Deisch J, Raisanen J, Rakheja D (2011) Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors. Pediatr Dev Pathol 14:353-359. doi:10.2350/10-09-0902-OA.1
4. Eberhart CG, Brat DJ, Cohen KJ, Burger PC (2000) Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 3:346-352 (Pubitemid 30421949)
5. Gessi M, Giangaspero F, Lauriola L et al (2009) Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol 33:211-217. doi:10.1097/PAS.0b013e318186235b
6. Hoos A, Cordon-Cardo C (2001) Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 81:1331-1338 (Pubitemid 32980155)
7. Judkins AR, Ellison DW (2010) Ependymoblastoma: dear, damned, distracting diagnosis, farewell!*. Brain Pathol 20:133-139. doi:10.1111/j.1750-3639. 2008.00253.x
8. Kallioniemi OP, Wagner U, Kononen J, Sauter G (2001) Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 10:657-662 (Pubitemid 32331572)
9. Kleinman CL, Gerges N, Papillon-Cavanagh S et al (2014) Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR. Nat Genet 46:39-44. doi:10.1038/ng.2849
10. Korshunov A, Remke M, Gessi M et al (2010) Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol 120:253-260. doi:10.1007/s00401-010- 0688-8
11. Korshunov A, Ryzhova M, Jones DT et al (2012) LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol 124:875-881. doi:10.1007/s00401-012-1068-3
12. Korshunov A, Sturm D, Ryzhova M et al (2013) Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol. doi:10.1007/s00401-013-1228-0
13. Li M, Lee KF, Lu Y et al (2009) Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 16:533-546. doi:10.1016/j.ccr.2009.10.025
14. Louis DN, International Agency for Research on Cancer (2007) WHO classification of tumours of the central nervous system. International Agency for Research on Cancer, France
15. Mao XG, Hutt-Cabezas M, Orr BA et al (2013) LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget 4:1050-1064
16. Nobusawa S, Yokoo H, Hirato J et al (2012) Analysis of chromosome 19q13.42 amplification in embryonal brain tumors with ependymoblastic multilayered rosettes. Brain Pathol 22:689-697. doi:10.1111/j.1750-3639.2012. 00574.x
17. Picard D, Miller S, Hawkins CE et al (2012) Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol 13:838-848. doi:10.1016/S1470- 2045(12)70257-7
18. Ray A, Ho M, Ma J et al (2004) A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10:7613-7620. doi:10.1158/1078- 0432.CCR-04-0499 (Pubitemid 39557524)
19. Spence T, Perotti C, Sin-Chan P et al (2014) A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes. Neuro-oncology 16:62-71. doi:10.1093/neuonc/not162
20. Suvasini R, Shruti B, Thota B et al (2011) Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3 K/MAPK) pathways by modulating IGF-2. J Biol Chem 286:25882-25890. doi:10.1074/jbc.M110. 178012
21. Woehrer A, Slavc I, Peyrl A et al (2011) Embryonal tumor with abundant neuropil and true rosettes (ETANTR) with loss of morphological but retained genetic key features during progression. Acta Neuropathol 122:787-790. doi:10.1007/s00401-011-0903-2
22. Zhu H, Shyh-Chang N, Segre AV et al (2011) The Lin28/let-7 axis regulates glucose metabolism. Cell 147:81-94. doi:10.1016/j.cell.2011.08.033